Column GROUP Ii, L.P., 10% Owner at RAPT Therapeutics, Inc. (RAPT), sold 350,406 shares at $37.31 ($13.0M) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Open-market sale of $13.0M RAPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.71 | 1,400 | $50K | 0.4% |
| 2 | $35.75 | 1,496 | $53K | 0.4% |
| 3 | $35.77 | 1,700 | $61K | 0.5% |
| 4 | $35.77 | 1,700 | $61K | 0.5% |
| 5 | $36.79 | 29,634 | $1.1M | 8.4% |
| 6 | $36.79 | 29,634 |
| $1.1M |
| 8.4% |
| 7 | $36.85 | 32,211 | $1.2M | 9.2% |
| 8 | $36.85 | 32,211 | $1.2M | 9.2% |
| 9 | $36.92 | 42,151 | $1.6M | 12.0% |
| 10 | $36.92 | 42,151 | $1.6M | 12.0% |
| 11 | $37.27 | 25,351 | $945K | 7.3% |
| 12 | $37.27 | 25,351 | $945K | 7.3% |
| 13 | $37.31 | 2,926 | $109K | 0.8% |
| 14 | $37.31 | 10,807 | $403K | 3.1% |
| 15 | $37.31 | 2,926 | $109K | 0.8% |
| 16 | $37.31 | 10,807 | $403K | 3.1% |
| 17 | $37.21 | 11,476 | $427K | 3.3% |
| 18 | $37.21 | 11,476 | $427K | 3.3% |
| 19 | $37.22 | 12,939 | $482K | 3.7% |
| 20 | $37.22 | 12,939 | $482K | 3.7% |
| 21 | $37.67 | 4,400 | $166K | 1.3% |
| 22 | $37.70 | 4,720 | $178K | 1.4% |
| Total | $37.01 avg | 350,406 | $13.0M | 100% |
| Filing → |
| NGM | BUY | 2019-10-21 | $1.4M | — | Filing → |
| NGM | BUY | 2019-08-09 | $3.1M | — | Filing → |
| NGM | BUY | 2019-05-13 | $496K | — | Filing → |